Printer Friendly

AFFYMAX ANNOUNCES UNDERWRITERS HAVE EXERCISED OVER-ALLOTMENT OPTION OF 600,000 SHARES

 AFFYMAX ANNOUNCES UNDERWRITERS HAVE EXERCISED
 OVER-ALLOTMENT OPTION OF 600,000 SHARES
 AMSTERDAM, The Netherlands, Dec. 18 /PRNewswire/ -- Affymax N.V. announced today that the underwriters of its public offering have exercised their entire over-allotment option of 600,000 shares in addition to the 4 million shares which were sold on Dec. 17, 1991.
 Goldman, Sachs & Co. and Alex. Brown & Sons Inc. are the underwriters for the offering.
 Affymax, a Netherlands corporation headquartered in Amsterdam, is developing new technologies to accelerate the pace of drug discovery. Affymax is applying these technologies across a broad range of diseases to discover and develop drugs independently and in collaboration with established pharmaceutical companies. The company's research and development activities are primarily performed by its wholly owned subsidiary Affymax Research Institute, located in Palo Alto, Calif.
 -0- 12/18/91
 /CONTACT: Diana Kapp or David Singer, 415-496-2300, both of Affymax/ CO: Affymax N.V. ST: California IN: MTC SU:


DG -- SJ003 -- 3664 12/18/91 20:38 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 18, 1991
Words:163
Previous Article:CHRISTMAS HOLIDAY: GAS PRICES DROP 3 CENTS
Next Article:GCI ANNOUNCES A REDUCTION IN WORK FORCE
Topics:


Related Articles
UNDERWRITERS' OPTION EXERCISED IN ARAMED UNIT OFFERING AND GENSIA COMMON STOCK OFFERING
NOVA PHARMACEUTICAL UNDERWRITERS EXERCISE OVER-ALLOTMENT OPTION
Dyax Announces Exercise of Underwriters' Overallotment Option.
Bradley Pharmaceuticals Announces Pricing of Follow-on Offering.
Bradley Pharmaceuticals Announces Exercise of Over-allotment Option.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters